Big Buttons

• CALL TO ACTION: Tell FDA to deny drugmakers’ request

  Drugmakers are urging FDA to prohibit compounded GLP-1s. FDA needs to hear from you and your patients NOW! read more →

• APC to FDA: Just say no to Lilly

  This week APC's lawyers sent a formal comment to the FDA about Eli Lilly’s request that tirzepatide be added to the Demonstrably Difficult to Compound list. read more →

• California BOP sends proposed compounding regs to comment period

  The California State Board of Pharmacy decided to move the modified proposed sterile compounding regulations forward to a 30-day comment period. read more →

• Checking in on the post-Chevron fallout

  What’s happened in the world of federal regulation since the end of Chevron? read more →

• Hi, Noom!

  Welcome to our newest Bronze-level Corporate Patron, Noom! read more →

• PFMs can get 2.5% credit card processing

  A new benefit for APC’s Pharmacy/Facility Members: They may be able to cut their credit card processing fees to just 2.5% – 2.8%. read more →

• Phoenix compounders, rise!

  The latest of APC’s new regional meetings — CompoundED UpDATE — is coming to the Phoenix area December 5. read more →

• APC election results: directors and bylaws

  See the results of APC's elections, including four new directors and several changes to our bylaws. read more →

More News

Earlier this year, APC worked with the University of Mary Washington’s Center for Business Research (CBR), polling 19,000 compounders across America about their businesses: prescriptions, employment, outsourcing, demographics, concerns, and more.

We received replies from every geographic and practice area, and the result is the most detailed profile of pharmacy compounding in years.

What do they compound? How much? Where are they licensed? What benefits do they offer employees? And more.

It paints a clearer picture than we’ve ever had — one we can share with policymakers, patients, and media to inform them about the profession.

We’ll be releasing the finished report, “A Snapshot of Pharmacy Compounding in America,” in mid-September. And on September 15 we’ll be hosting a town hall briefing — open to all — with CBR’s Dr. Lance Gentry giving an overview of the results.

Join us via Zoom: Wednesday, September 15, from 4:00 to 5:00 EDT. It’s free and open to all, but registration is required: A4PC.org/snapshot.